The Pro-Stim graft provides surgeons with the osteoconductive base material derived from its Pro-Dense graft, which is a combination of calcium sulfate and calcium phosphate materials, but adds a high volume of osteoinductive demineralized bone matrix to the formulation.
A full roll-out in the United States and some international markets is planned for the second half of 2010.
Read Wright Medical Group’s release on the Pro-Stim bone graft substitute.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
